Advertisement
A comparison of three treatments for opioid dependence indicates that patients given buprenorphine in the emergency department do better than those given only referrals. The research was published in the April 28 issue of the Journal of the American Medical Association.

Buprenorphine Given in ER Benefits Opioid Dependent

0
Works better than simple referrals in opioid-dependent patients, researchers say
Genetic variations may hold clues to rheumatoid arthritis -- suggesting not only who will develop the condition

Genetic Variations Could Hold Keys to Rheumatoid Arthritis Care

0
New research reveals clues to disease severity, potential outcomes
Less than one-quarter of sickle cell anemia patients who should have been taking hydroxyurea within a year of their last pain crisis actually were taking the medication

Hydroxyurea Underutilized for Patients With Sickle Cell

0
Only 23 percent using the drug within a year of their last pain crisis
Westernization of the diet induces changes in biomarkers of colon cancer risk within two weeks

Colon Cancer Risk Markers Appear Within Two Weeks of Diet Change

0
More polyps, other markers of colon tumor risk in those eating 'Western' high-fat, low-fiber fare
The first generic versions of the atypical antipsychotic drug Abilify (aripiprazole) have been approved by the U.S. Food and Drug Administration to treat schizophrenia or bipolar disorder.

FDA Approves First Generic Abilify

0
For treatment of bipolar disorder or schizophrenia
The majority of oral antibiotic course durations for adult acne follow guidelines

Most Adult Acne Antibiotic Course Durations Follow Guidelines

0
However, topical retinoids are underused in conjunction with antibiotics for adult acne
Chronic obstructive pulmonary disease is already the third leading cause of death in the world

COPD May Increase Risk of Sudden Cardiac Death

0
COPD is third leading cause of death in the world
Preliminary research suggests that an HIV vaccine in development can ramp up the body's immune system

Experimental HIV Vaccine Could Boost Efficacy of HAART

0
Findings for patients on highly-active antiretroviral therapy
Kybella (deoxycholic acid) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe submental fat.

FDA Approves Kybella for Reducing Submental Fat

0
Use for fat outside submental area not approved, not recommended
Physicians and patients should be aware of the persistently increased risk of cardiovascular diseases throughout life after Hodgkin's lymphoma

Higher CV Risks Seen for Hodgkin’s Lymphoma Survivors

0
Chemotherapy, radiation may damage the heart for decades to come